Publisher of the most cited open-access journals in their fields.
This section is dedicated to publishing important and innovative biological, psychological and social research into the causes and treatment of Mood and Anxiety disorders. We welcome contributions from across scientific and clinical disciplines including clinical psychiatry, neuroimaging, addictions, cognitive neuroscience, inflammation and animal research. Our ultimate goal is to improve the lives of people with mood and anxiety disorders by rapidly communicating and publicizing key discoveries, fostering collaborative multidisciplinary research, and providing a forum where ideas can be exchanged and debated.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, PsycINFO, EMBASE
PMCID: all published articles receive a PMCID
Mood and Anxiety Disorders welcomes submissions of the following article types: Book Review, Case Report, Clinical Study Protocol, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Technology Report.
All manuscripts must be submitted directly to the section Mood and Anxiety Disorders, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Mood and Anxiety Disorders will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Psychiatry.